XML 25 R9.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Number of Common Shares outstanding
Number of treasury shares
Additional paid-in capital
Common Shares held in treasury
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Beginning balance at Dec. 31, 2019 $ 289,904 $ 13,750     $ 225,607 $ (50,773) $ 206,542 $ 13,750 $ (91,472)
Beginning balance (in shares) at Dec. 31, 2019     27,408            
Beginning balance (in shares) at Dec. 31, 2019       1,558          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income (7,950)           (7,950)    
Unrealized loss on derivatives, net (840) [1]               (840)
Currency translation adjustments 2,677               2,677
Issuance of Common Shares ( in shares)     285 (285)          
Repurchased Common Shares for treasury, net (in shares)     (80) 80          
Repurchased Common Shares for treasury, net 5,286         5,286      
Common Share repurchase program (in shares)     (607) 607          
Common Share repurchase program (4,995)       10,000 (14,995)      
Share-based compensation, net (1,198)       (1,198)        
Ending balance at Dec. 31, 2020 296,634       234,409 (60,482) 212,342   (89,635)
Ending balance (in shares) at Dec. 31, 2020     27,006            
Ending balance (in shares) at Dec. 31, 2020       1,960          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 3,406           3,406    
Unrealized loss on derivatives, net 1,019 [1]               1,019
Currency translation adjustments (8,408)               (8,408)
Issuance of Common Shares ( in shares)     265 (265)          
Repurchased Common Shares for treasury, net (in shares)     (80) 80          
Repurchased Common Shares for treasury, net 5,218         5,218      
Share-based compensation, net (1,919)       (1,919)        
Ending balance at Dec. 31, 2021 $ 295,950       232,490 (55,264) 215,748   (97,024)
Ending balance (in shares) at Dec. 31, 2021 27,191   27,191            
Ending balance (in shares) at Dec. 31, 2021 1,775     1,775          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income $ (14,056)           (14,056)    
Unrealized loss on derivatives, net 53 [1]               53
Currency translation adjustments (6,171)               (6,171)
Issuance of Common Shares ( in shares)     193 (193)          
Repurchased Common Shares for treasury, net (in shares)     (43) 43          
Repurchased Common Shares for treasury, net 4,898         4,898      
Share-based compensation, net 268       268        
Ending balance at Dec. 31, 2022 $ 280,942       $ 232,758 $ (50,366) $ 201,692   $ (103,142)
Ending balance (in shares) at Dec. 31, 2022 27,341   27,341            
Ending balance (in shares) at Dec. 31, 2022 1,625     1,625          
[1] Net of tax expense (benefit) of $14, $271 and $(223) for the years ended December 31, 2022, 2021 and 2020, respectively.